NIAD develops protein that may help build new malaria vaccine
HQ Team September 28, 2023: Using structural and mechanistic information of two parasitic proteins, scientists have built a new component for a vaccine.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team September 28, 2023: Using structural and mechanistic information of two parasitic proteins, scientists have built a new component for a vaccine.
HQ Team September 27, 2023: Earthworms help produce 140 MMT of food a year â about the amount of cereal grains grown by.
HQ Team September 27, 2023: Thirty-three governments got dragged to the Strasbourg Court by six Portugal adolescents, who argued the states were acting.
HQ Team September 27, 2023: India, the third-largest pharmaceutical industry in the world by volume, has unveiled a policy to make the South.
HQ Team September 27, 2023: Higher temperatures led to a rise in hospital visits for the treatment of alcohol and substance-related disorders in.
HQ Team September 26, 2023: Researchers at Swedenâs Lund University have identified a new biomarker to detect Parkinsonâs disease before a person develops.
HQ Team September 26, 2023: After working on deadly spiders for almost two decades, Brazilian researchers have developed a synthetic molecule from the.
HQ Team September 26, 2023: Amazon is investing $4 billion to take up an unspecified minority stake in artificial intelligence systems company Anthropic..
HQ Team September 25, 2023: Record-breaking heatwaves have impacted agricultural production in Japan and the East Asian nation may look at imports to.
HQ Team September 25, 2023: Novo Nordisk and Valo Health, Inc., have signed a $2.7 billion pact to discover and develop novel treatments.